Clinical Trial Update: NIR-Guided Sentinel Lymph-Node Mapping for Esophageal Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update on near-infrared-guided sentinel lymph-node mapping for esophageal cancer; the study sponsored by Dana-Farber Cancer Institute has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Esophageal Cancer | Phase 1 | Status: COMPLETED